Skip to main content
Clinical Trials/NCT02650843
NCT02650843
Active, Not Recruiting
N/A

Non-motor Symptoms and Brain Dopamine Transporter Binding: An Observational Study in Parkinsonism

Turku University Hospital0 sites455 target enrollmentJanuary 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Turku University Hospital
Enrollment
455
Primary Endpoint
DAT SPECT striatal specific binding ratio
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

This project aims to clarify the role non-motor symptoms in the development of Parkinson's disease (PD) and to improve diagnostics at very early stages of PD. The project involves multidimensional measures of disease biomarkers together with brain dopamine transporter (DAT) imaging with [123I]FP-CIT single photon emission computed tomography (SPECT).

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
December 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or Female
  • Age 18-100 years
  • Referred for clinical DAT SPECT in Turku or Helsinki

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

DAT SPECT striatal specific binding ratio

Time Frame: Up to 10 years

Similar Trials